Hawaii is currently home to 219 active clinical trials, seeking participants for engagement in research studies. These trials take place at a variety of cities in the state, including Honolulu, 'Aiea, Lihue and Wailuku. Whether you're a healthy volunteer interested in paid medical research or someone seeking trials related to a specific condition, the state offers a diverse array of opportunities in your vicinity.
CGX1321 in Subjects With Advanced Solid Tumors and CGX1321 With Pembrolizumab or Encorafenib + Cetuximab in Subjects With Advanced GI Tumors (Keynote 596)
Recruiting
This is a multicenter, open-label study conducted in two phases: Phase 1 consisting of a CGX1321 Single Agent Dose Escalation Phase in solid tumors, CGX1321 Single Agent Dose Expansion Phase in GI tumors and Roll-over Cohort of CGX1321 and pembrolizumab in subjects who have progressed on single agent CGX1321 and Phase 1b consisting of CGX1321 in combination with pembrolizumab in colorectal tumors and CGX1321 in combination with encorafenib + cetuximab in BRAFV600E mutated colorectal tumors. Both... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
01/11/2022
Locations: Hawaii Cancer Center, Honolulu, Hawaii
Conditions: Solid Tumors, GI Cancer
Transcutaneous Electrical Nerve Stimulation for Post-Cesarean Pain Control
Recruiting
Purpose of study is to evaluate the efficacy of transcutaneous electrical nerve stimulation (TENS) for post-operative pain control after a cesarean delivery compared to placebo and no TENS.
Gender:
Female
Ages:
18 years and above
Trial Updated:
05/21/2020
Locations: Nicole Kurata, Honolulu, Hawaii
Conditions: Transcutaneous Electric Nerve Stimulation, Analgesia, Cesarean Section
Survivorship and Patient Outcomes of Primary Total Hip Arthroplasty With the Ovation Hip System
Recruiting
The objective of this study is to evaluate patient outcomes in regards to safety and effectiveness based on the clinical performance of the reference devices to further support the assessment of residual risk identified in the Clinical Evaluation Report for the Ortho Development Hip System.
Gender:
All
Ages:
Between 18 years and 80 years
Trial Updated:
06/13/2019
Locations: Straub Medical Center, Honolulu, Hawaii
Conditions: Joint Diseases, Osteoarthritis, Hip, Rheumatoid Arthritis, Psoriatic Arthritis, Avascular Necrosis of Hip